Skip to content
10-K

Annual Report

DARA BioSciences, Inc.

0001214659-15-001939

← back to feed
Filed
Mar 3, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Feb 26, 2015 19.76M sh
Capex FY 2014 · Dec 31, 2014 $2.14K
Capex FY 2014 · Dec 31, 2013 $12.22K
Operating Cash Flow FY 2014 · Dec 31, 2014 −$7.99M
Operating Cash Flow FY 2014 · Dec 31, 2013 −$9.13M
Cash And Equivalents FY 2014 · Dec 31, 2014 $12.03M
Cash And Equivalents FY 2014 · Dec 31, 2013 $3.43M
Cash And Equivalents FY 2014 · Dec 31, 2012 $6.5M
Stockholders Equity FY 2014 · Dec 31, 2014 $13.92M
Stockholders Equity FY 2014 · Dec 31, 2013 $6.61M
Stockholders Equity restated FY 2014 · Dec 31, 2012 $8.99M
Current Liabilities FY 2014 · Dec 31, 2014 $3.75M
Current Liabilities FY 2014 · Dec 31, 2013 $1.68M
Total Liabilities FY 2014 · Dec 31, 2014 $3.84M
Total Liabilities FY 2014 · Dec 31, 2013 $2.43M
Current Assets FY 2014 · Dec 31, 2014 $13.77M
Current Assets FY 2014 · Dec 31, 2013 $3.89M
Total Assets FY 2014 · Dec 31, 2014 $17.75M
Total Assets FY 2014 · Dec 31, 2013 $7.99M
Sga Expense FY 2014 · Dec 31, 2014 $4.5M
Sga Expense FY 2014 · Dec 31, 2013 $4.27M
Rd Expense FY 2014 · Dec 31, 2014 $475.99K
Rd Expense FY 2014 · Dec 31, 2013 $1.95M
Net Income FY 2014 · Dec 31, 2014 −$9M
Net Income FY 2014 · Dec 31, 2013 −$9.97M
Operating Income FY 2014 · Dec 31, 2014 −$9.4M
Operating Income FY 2014 · Dec 31, 2013 −$10.49M
Cost Of Revenue FY 2014 · Dec 31, 2014 $443.02K
Cost Of Revenue FY 2014 · Dec 31, 2013 $218.93K
Revenue FY 2014 · Dec 31, 2014 $1.89M
Revenue FY 2014 · Dec 31, 2013 $419.32K